Diacerein for the treatment of osteoarthritis
Feb 11 Following an update from the manufacturer on their regulatory timings the timelines for this MTA are to be confirmed.
 
Status Discontinued
Decision Selected
Process TA
Referral date 01 March 2010
Topic area
  • Musculoskeletal
Description

Scoped within batch 10

Provisional Schedule

Closing date for invited submissions / evidence submission: TBC
1st appraisal committee meeting: TBC

Project Team

Communications manager: TBC
Executive Lead: TBC
Project manager: TBC
Technical Lead: TBC

Timeline

Key events during the development of the guidance:

Date Update
19 January 2023 Discontinued. Feb 11 Following an update from the manufacturer on their regulatory timings the timelines for this MTA are to be confirmed.
21 December 2018 Suspended. Suspended

For further information on our processes and methods, please see our CHTE processes and methods manual